alprenolol has been researched along with albuterol in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (39.13) | 18.7374 |
1990's | 4 (17.39) | 18.2507 |
2000's | 8 (34.78) | 29.6817 |
2010's | 2 (8.70) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bultsma, T; Donné-Op den Kelder, GM; Rademaker, B; Timmerman, H | 1 |
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Topliss, JG; Yoshida, F | 1 |
Baker, JG | 1 |
Deupi, X; Farrens, D; Kobilka, B; Parnot, C; Ratnala, VR; Swaminath, G; Yao, X | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Frisk-Holmberg, M; Ostman, J | 1 |
Chermat, R; Francès, H; Puech, AJ; Simon, P | 1 |
Bianchetti, A; Gonalons, N; Guitard, J; Keane, PE; Langlois, X; Le Fur, G; Martin, P; Simiand, J; Soubrié, P | 1 |
Achtelik, W; Döhler, KD; Gubala, E; Jarzab, B; Lindner, G; Pogorzelska, E | 1 |
Abel, PW; May, JM; Minneman, KP | 1 |
Day, MD; Roach, AG | 1 |
Cash, JD; Da Costa, J; Gader, AM | 1 |
Crankshaw, DJ; Ruzycky, AL | 1 |
Kim, GD; MacEwan, DJ; Milligan, G | 1 |
Coleman, RA; Johnson, M; Nials, AT; Vardey, CJ | 1 |
Chong, LK; Drury, DE; Ghahramani, P; Peachell, PT | 1 |
Vigh, G; Zhu, W | 1 |
Horinouchi, T; Koike, K | 1 |
Almeida, VK; Larive, CK | 1 |
1 review(s) available for alprenolol and albuterol
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
22 other study(ies) available for alprenolol and albuterol
Article | Year |
---|---|
Mapping of the beta 2-adrenoceptor on Chang liver cells. Differences between high- and low-affinity receptor states.
Topics: Cell Membrane; Cells, Cultured; Guanylyl Imidodiphosphate; Hydrogen Bonding; Iodocyanopindolol; Liver; Models, Molecular; Pindolol; Protein Conformation; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 1988 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Algorithms; Animals; Cell Line; CHO Cells; Cricetinae; Dioxoles; Humans; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3 | 2005 |
Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Alprenolol; Amino Acid Sequence; Binding Sites; Crystallography, X-Ray; Epinephrine; Humans; Isoproterenol; Ligands; Models, Molecular; Molecular Sequence Data; Molecular Structure; Propanolamines; Protein Conformation; Protein Structure, Tertiary; Receptors, Adrenergic, beta-2; Sensitivity and Specificity; Spectrometry, Fluorescence | 2006 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Differential inhibition of lipolysis in human adipose tissue by adrenergic beta receptor blocking drugs.
Topics: Adipose Tissue; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Dose-Response Relationship, Drug; Female; Glycerol; Humans; In Vitro Techniques; Isoproterenol; Male; Norepinephrine; Practolol; Propranolol; Theophylline | 1977 |
Are psychopharmacological effects of beta-adrenergic stimulants central or peripheral?
Topics: Adrenergic beta-Agonists; Albuterol; Alprenolol; Animals; Apomorphine; Body Temperature; Injections, Intraperitoneal; Injections, Intraventricular; Isoproterenol; Male; Mice; Motor Activity; Oxotremorine; Reserpine | 1979 |
Antidepressant profile in rodents of SR 58611A, a new selective agonist for atypical beta-adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Antidepressive Agents; Behavior, Animal; Body Temperature; Clenbuterol; Humans; Imipramine; In Vitro Techniques; Male; Mice; Motor Activity; Propranolol; Receptors, Adrenergic, beta; Tetrahydronaphthalenes | 1992 |
Postnatal treatment of rats with beta-adrenergic agonists or antagonists influences differentiation of sexual brain functions.
Topics: Albuterol; Alprenolol; Animals; Animals, Newborn; Brain; Female; Isoproterenol; Luteinizing Hormone; Male; Orchiectomy; Ovariectomy; Rats; Rats, Inbred Strains; Sex Differentiation; Sexual Behavior, Animal; Testosterone | 1989 |
Binding of agonists and antagonists to beta-adrenoceptors in rat vas deferens: relationship to functional response.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Isoproterenol; Male; Pindolol; Rats; Receptors, Adrenergic, beta; Vas Deferens | 1985 |
Central alpha- and beta-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats.
Topics: Albuterol; Alprenolol; Animals; Atropine; Bethanidine; Blood Pressure; Cats; Cerebral Ventricles; Clonidine; Dopamine; Epinephrine; Female; Heart Rate; Hexamethonium Compounds; Injections; Isoproterenol; Lidocaine; Male; Norepinephrine; Pempidine; Phentolamine; Practolol; Propranolol; Rabbits; Rats; Receptors, Adrenergic; Sotalol; Species Specificity; Time Factors | 1974 |
The effect propranolol, alprenolol and practolol on the vibrinolytic and factor VIII responses to adrenaline and salbutamol in man.
Topics: Adult; Albuterol; Alprenolol; Epinephrine; Factor VIII; Fibrinolysis; Humans; Injections, Intravenous; Male; Plasminogen; Practolol; Propranolol; Pulse; Receptors, Adrenergic; Receptors, Drug | 1974 |
Characterization of putative beta-adrenoceptors in the myometrium of the pregnant ewe: correlation between the binding of [3H] dihydroalprenolol and the inhibition of myometrial contractility in vitro.
Topics: Adrenergic beta-Agonists; Albuterol; Alprenolol; Animals; Atenolol; Dihydroalprenolol; Dose-Response Relationship, Drug; Female; Myometrium; Pregnancy; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Sheep; Uterine Contraction | 1984 |
Analysis of the role of receptor number in defining the intrinsic activity and potency of partial agonists in neuroblastoma x glioma hybrid NG108-15 cells transfected to express differing levels of the human beta 2-adrenoceptor.
Topics: Adenylyl Cyclases; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Alprenolol; Dobutamine; Ephedrine; Epinephrine; Humans; Hybrid Cells; Isoproterenol; Receptors, Adrenergic, beta-2; Transfection; Tumor Cells, Cultured | 1995 |
The duration of action of non-beta 2-adrenoceptor mediated responses to salmeterol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Electric Stimulation; Gastric Fundus; Guinea Pigs; Humans; In Vitro Techniques; Male; Neutrophils; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Superoxides; Trachea | 1997 |
Influence of receptor reserve on beta-adrenoceptor-mediated responses in human lung mast cells.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Antibodies, Anti-Idiotypic; Histamine Release; Humans; Immunoglobulin E; In Vitro Techniques; Isoproterenol; Lung; Mast Cells; Receptors, Adrenergic, beta | 1998 |
Experimental verification of a predicted, hitherto unseen separation selectivity pattern in the nonaqueous capillary electrophoretic separation of weak base enantiomers by octakis (2,3-diacetyl-6-sulfato)-gamma-cyclodextrin.
Topics: Albuterol; Alprenolol; Cyclodextrins; Electrophoresis, Capillary; gamma-Cyclodextrins; Indicators and Reagents; Kinetics; Methadone; Metoprolol; Models, Theoretical; Stereoisomerism | 2000 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Insights into cyclodextrin interactions during sample stacking using capillary isotachophoresis with on-line microcoil NMR detection.
Topics: Albuterol; Alprenolol; Atenolol; Cyclodextrins; Diffusion; Electrolytes; Electrophoresis; Magnetic Resonance Spectroscopy; Propranolol; Protons; Sensitivity and Specificity; Terbutaline | 2005 |